AstraZeneca Self-Markets Nolvadex Generic; Zoladex Settlement Near

AstraZeneca is marketing its own generic version of Nolvadex (tamoxifen) to protect the company from claims that it is exploiting cancer patients in the final months of exclusivity for the drug